In addition to its master role in controlling type I interferon production and immune system regulation, IRF7 acts as an oncogene or tumor suppressor, depending on the cell types used for investigations (Zhang et al., 2004; Andrews et al., 2002). Here, IRF7 is linked to neoplasm.